Aortic Stents Grafts Market Size, Share, Growth, and Industry Analysis, By Type (Abdominal Aortic Stent Graft,Thoracic Aortic Stent Graft), By Application (Hospitals,Ambulatory Surgical Centers), Regional Insights and Forecast to 2035

Aortic Stents Grafts Market Overview

The global Aortic Stents Grafts Market is forecast to expand from USD 2665.22 million in 2026 and is expected to reach USD 3703.89 million by 2035, growing at a CAGR of 3.72% over the forecast period.

The Aortic Stents Grafts Market is developing steadily as healthcare systems increasingly favor minimally invasive approaches for managing complex aortic conditions. Endovascular repair can reduce surgical trauma, shorten hospital stays, and support faster postoperative recovery compared with selected open procedures. In 2026, endovascular approaches are estimated to account for more than 65% of eligible aortic repair procedures in several mature healthcare systems, supporting continued demand for advanced stent graft platforms. Product innovation is increasingly focused on precise deployment, improved fixation, enhanced conformability, lower-profile delivery systems, and designs capable of addressing anatomically challenging vessels.

In the USA, demand remains supported by a large population of older adults, established vascular-care infrastructure, advanced imaging capabilities, and relatively high adoption of minimally invasive cardiovascular procedures. Approximately 70% of major vascular centers are estimated to have dedicated endovascular capabilities, creating a broad installed base for Aortic Stents Grafts. Hospitals continue to represent the primary treatment environment because complex aortic interventions require advanced imaging, multidisciplinary teams, and post-procedure monitoring. Ambulatory Surgical Centers are gaining selective opportunities for appropriately screened lower-complexity procedures as device profiles, procedural workflows, and recovery pathways improve.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Market Driver: Rising adoption of minimally invasive aortic repair is supporting device demand, with endovascular approaches estimated to represent more than 65% of eligible procedures across several mature healthcare systems.
• Major Market Restraint: High device costs, complex anatomical requirements, and reimbursement limitations constrain adoption, with advanced endovascular procedures potentially requiring 20% to 35% higher procedural expenditure than standard interventions.
• Emerging Trends: Low-profile delivery systems and advanced imaging are improving procedural precision, with next-generation platforms reducing delivery-system diameters by approximately 15% compared with earlier device generations.
• Regional Leadership: North America is expected to lead the market, supported by mature vascular-care infrastructure, with the region projected to account for approximately 38% of global demand in 2026.
• Competitive Landscape: Manufacturers are emphasizing broader anatomical coverage and next-generation endovascular platforms, with leading development programs increasingly targeting more than 20% improvement in deployment precision and delivery flexibility.
• Market Segmentation: Abdominal Aortic Stent Graft is expected to lead product demand with approximately 62% share in 2026, while Hospitals should dominate applications at nearly 82% because complex procedures require specialized clinical infrastructure.
• Recent Development: Advanced fenestrated and branched endovascular technologies are expanding treatment options for complex anatomy, with specialized graft configurations now supporting repair strategies involving multiple visceral or branch vessels.

Latest Trends

The market is increasingly shaped by lower-profile delivery systems, improved graft materials, enhanced fixation mechanisms, and more precise deployment technologies. Device manufacturers are concentrating on reducing delivery-system size while maintaining structural strength and sealing performance, particularly for patients with small or tortuous access vessels. Next-generation systems are estimated to achieve approximately 15% lower delivery profiles than several earlier-generation platforms, potentially widening procedural eligibility. Three-dimensional computed tomography reconstruction and intraoperative imaging are also becoming more important because accurate anatomical planning can reduce positioning errors and improve graft selection before intervention.

Another important trend is the expansion of customized endovascular solutions for anatomically complex patients. Fenestrated and branched configurations are allowing physicians to preserve blood flow to critical branch vessels while treating aneurysmal disease in challenging anatomical locations. Approximately 18% of complex aortic repair programs in advanced vascular centers are estimated to involve specialized fenestrated or branched technologies. Manufacturers are also refining graft materials and fixation systems to improve long-term stability, reduce migration risk, and accommodate varying vessel diameters. These developments are increasing the range of patients who can potentially be considered for endovascular intervention.

Market Dynamics

Driver

"Growing preference for minimally invasive aortic repair is expanding demand for endovascular devices."

Increasing preference for minimally invasive cardiovascular treatment is the principal growth driver for Aortic Stents Grafts. Endovascular repair can reduce incision size, blood loss, intensive-care requirements, and postoperative recovery time for appropriately selected patients. In mature healthcare markets, endovascular approaches are estimated to account for more than 65% of eligible aortic repair procedures, demonstrating the growing importance of catheter-based intervention. This transition is particularly relevant as healthcare systems seek procedures that can reduce hospitalization requirements while maintaining effective treatment outcomes.

Population aging further supports demand because aortic aneurysm prevalence generally increases with age and cardiovascular risk exposure. In major developed healthcare markets, individuals aged 65 years and older represent more than 17% of the population, creating a substantial patient pool requiring vascular screening and intervention. Hospitals are therefore expanding endovascular capabilities, while vascular specialists are increasingly using advanced imaging to identify appropriate candidates. Approximately 70% of major vascular centers in the USA are estimated to maintain dedicated endovascular capabilities, supporting consistent utilization of stent graft technologies.

Restraint

"High procedural costs and anatomical complexity continue to limit broader device adoption."

Aortic Stents Grafts involve sophisticated materials, specialized delivery systems, advanced imaging, and highly trained clinical teams, resulting in substantial procedural costs. Complex endovascular repairs can require approximately 20% to 35% higher expenditure than simpler interventions because of longer planning times, specialized graft configurations, and additional imaging requirements. These costs can restrict adoption in healthcare systems with limited reimbursement budgets or constrained access to advanced vascular technologies.

Anatomical suitability is another important limitation. Tortuous vessels, narrow access arteries, severe calcification, short landing zones, and complex branch anatomy can prevent the use of standard graft configurations. Approximately 15% to 20% of patients evaluated for endovascular treatment may require additional anatomical assessment or specialized planning before a suitable device can be selected. Such requirements increase procedure complexity and can shift patients toward alternative treatment strategies. Long-term surveillance also remains important because post-procedure imaging is required to monitor graft position, sealing, and potential endoleaks.

Opportunity

"Advanced graft designs are expanding treatment options for increasingly complex aortic anatomy."

Product development is creating opportunities to treat patients who previously presented significant anatomical challenges for standard endovascular repair. Fenestrated and branched stent grafts can preserve blood flow through important branch vessels while allowing treatment of more complex aneurysmal disease. Approximately 18% of complex aortic repair programs at advanced vascular centers are estimated to use specialized graft configurations. Continued improvement in customization, imaging, and deployment systems can expand the addressable patient population while supporting more individualized treatment planning.

Lower-profile delivery systems also offer an important growth opportunity because reduced device diameter can improve access in patients with smaller or more challenging arteries. Newer systems are estimated to reduce delivery profiles by approximately 15% compared with selected earlier-generation platforms. Improved flexibility and navigation can further support treatment in tortuous anatomy. Ambulatory Surgical Centers may gradually become an additional opportunity for selected procedures as device profiles decline and recovery pathways become more efficient, although Hospitals are expected to remain dominant for complex interventions.

Challenge

"Long-term device performance and procedural precision remain critical clinical challenges."

Long-term durability remains a central challenge because stent grafts must maintain structural integrity, sealing, fixation, and positional stability over many years. Endoleaks, migration, graft deformation, limb occlusion, and other complications can require additional intervention or prolonged imaging surveillance. Approximately 10% to 15% of patients undergoing certain endovascular repair procedures may require additional intervention or close monitoring because of post-procedure complications or device-related concerns, depending on anatomy and procedure complexity.

Procedural precision is equally important because even small positioning errors can affect sealing zones or branch-vessel preservation. Advanced three-dimensional imaging and intraoperative navigation can improve accuracy, but they increase dependence on specialized equipment and trained personnel. Approximately 60% of complex vascular centers are estimated to use advanced three-dimensional imaging or equivalent planning technologies for selected cases. Manufacturers must therefore balance device flexibility, deployment control, durability, and ease of use while maintaining regulatory and clinical-performance requirements.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

Segmentation Analysis

By Types

Abdominal Aortic Stent Graft: Abdominal Aortic Stent Graft is expected to remain the leading product type, accounting for approximately 62% of global market demand in 2026. Its dominant position reflects the high volume of endovascular procedures performed for abdominal aortic aneurysm management and the broad availability of established graft platforms. Product innovation is increasingly focused on improving fixation, sealing, delivery flexibility, and anatomical coverage. Approximately 65% of standard endovascular aortic procedures in mature markets are estimated to involve abdominal applications, reinforcing the segment's importance to overall device utilization.

Thoracic Aortic Stent Graft: Thoracic Aortic Stent Graft is projected to represent approximately 38% of market demand in 2026 and is gaining importance as physicians increasingly use endovascular approaches for appropriately selected thoracic aortic conditions. The segment benefits from improvements in graft flexibility, conformability, and deployment control. Approximately 30% of complex thoracic procedures are estimated to require enhanced imaging or specialized planning because of anatomical variation. Continued development of branched and fenestrated configurations is expected to broaden treatment options for patients requiring preservation of major branch vessels.

By Applications

Hospitals: Hospitals are expected to dominate the application segment with approximately 82% of global market demand in 2026. Aortic stent graft procedures frequently require advanced imaging, vascular specialists, anesthesia services, surgical backup, intensive monitoring, and access to emergency intervention capabilities, making hospitals the preferred setting for most procedures. Approximately 75% of complex aortic interventions are estimated to occur in tertiary or advanced hospitals with dedicated vascular teams. Hospitals are also better positioned to manage complications and conduct postoperative imaging, supporting their continued dominance through the forecast period.

Ambulatory Surgical Centers: Ambulatory Surgical Centers are projected to account for approximately 18% of market demand in 2026, with adoption concentrated in carefully selected lower-complexity cases and healthcare systems possessing advanced outpatient infrastructure. Improvements in lower-profile delivery systems and standardized procedural protocols are gradually creating opportunities for shorter-stay interventions. Approximately 12% of eligible endovascular cases are estimated to have potential for outpatient or short-stay management where clinical protocols and patient selection permit. Expansion will depend on reimbursement structures, specialist availability, imaging capabilities, emergency backup, and the continued improvement of procedural efficiency.

Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America is expected to maintain the leading position in the Aortic Stents Grafts Market, supported by advanced vascular-care infrastructure, high adoption of minimally invasive procedures, established reimbursement systems, and a large population requiring cardiovascular intervention. The region is projected to account for approximately 38% of global market demand in 2026. The United States represents the largest regional contributor, with approximately 70% of major vascular centers estimated to maintain dedicated endovascular capabilities. Hospitals remain the principal treatment environment because complex aortic procedures require advanced imaging, specialist teams, and immediate access to surgical support.

Technology adoption is accelerating across North American vascular centers as physicians increasingly use three-dimensional imaging, low-profile delivery systems, branched grafts, and fenestrated configurations. Approximately 61% of major centers are estimated to use advanced three-dimensional imaging for selected complex aortic procedures. Lower-profile devices are also expanding treatment options for patients with challenging access anatomy, while improved fixation and sealing technologies are designed to enhance long-term device performance. Through 2035, North American demand should remain supported by population aging, established screening programs, procedural innovation, and continued migration from open surgical repair toward endovascular treatment.

Europe

Europe is projected to represent approximately 30% of global Aortic Stents Grafts Market demand in 2026. The region benefits from mature vascular-care systems, extensive specialist networks, established endovascular expertise, and increasing demand for less invasive treatment among aging populations. Germany, the United Kingdom, France, Italy, and Spain represent important markets, while approximately 64% of major European vascular centers are estimated to have dedicated endovascular treatment capabilities. Hospitals remain the dominant application setting because many procedures require specialized imaging and multidisciplinary vascular teams.

European healthcare providers are placing greater emphasis on procedural efficiency, device durability, and patient selection as healthcare systems manage increasing cardiovascular-care requirements. Approximately 22% of complex endovascular procedures are estimated to use fenestrated or branched graft technologies at advanced centers, reflecting the growing importance of customized treatment. Low-profile systems and improved deployment mechanisms are also supporting broader procedural eligibility. Through 2035, market expansion should be supported by population aging, increased screening for aortic disease, technological improvements, and continued adoption of minimally invasive interventions, although reimbursement constraints may influence the pace of device uptake.

Asia-Pacific

Asia-Pacific is expected to account for approximately 21% of global Aortic Stents Grafts Market demand in 2026 and should record comparatively strong expansion through 2035. Increasing healthcare expenditure, improving vascular infrastructure, urbanization, and rising awareness of minimally invasive cardiovascular treatment are expanding the addressable patient population. China, Japan, South Korea, Australia, and India represent important regional markets. Approximately 43% of advanced hospitals in major metropolitan areas are estimated to have access to dedicated endovascular capabilities, although availability remains considerably lower in smaller cities and developing healthcare markets.

Regional manufacturers and international suppliers are increasingly focusing on lower-profile systems, cost-efficient device platforms, and products adapted to anatomical characteristics common in Asian patient populations. Approximately 28% of new endovascular programs established across developing Asia-Pacific markets are estimated to prioritize minimally invasive vascular procedures. Hospitals are expected to remain the principal application because complex aortic repair requires advanced imaging and specialized clinical teams. Through 2035, market development should benefit from expanding hospital infrastructure, increasing specialist training, improving reimbursement coverage, and gradual diffusion of advanced graft technologies.

Middle East and Africa

Middle East and Africa is projected to contribute approximately 6% of global Aortic Stents Grafts Market demand in 2026. Demand is concentrated in countries with developed tertiary-care infrastructure, particularly major metropolitan healthcare hubs. Approximately 34% of advanced hospitals in the region are estimated to have access to specialized endovascular treatment capabilities. Growing healthcare investment, expansion of private hospital networks, and increasing adoption of minimally invasive cardiovascular procedures are supporting market development.

Access to highly trained vascular specialists and sophisticated imaging remains uneven across the region. Approximately 31% of complex aortic procedures are estimated to be concentrated within a relatively small number of major tertiary hospitals, highlighting the importance of specialist centers. Healthcare providers are increasingly investing in advanced imaging, catheterization laboratories, and multidisciplinary cardiovascular programs. Through 2035, demand should benefit from healthcare modernization, cardiovascular disease awareness, and expansion of specialized hospitals, although device affordability, reimbursement limitations, and specialist availability will remain important market considerations.

Rest of World

Rest of World is expected to account for approximately 5% of global Aortic Stents Grafts Market demand in 2026, with Latin America and other developing healthcare markets contributing most of the regional activity. Adoption is increasing as hospitals expand cardiovascular capabilities and physicians receive greater access to minimally invasive technologies. Approximately 27% of major hospitals in developing markets are estimated to have established endovascular capabilities, leaving substantial room for additional adoption as healthcare infrastructure improves.

Market development is increasingly supported by physician training, improved access to advanced imaging, and the expansion of specialized cardiovascular centers. Approximately 19% of newly established vascular programs in developing markets are estimated to include endovascular aortic repair within their initial service portfolio. Hospitals will remain the principal application because procedures often require specialized imaging, anesthesia, vascular expertise, and postoperative monitoring. Through 2035, Rest of World should experience steady expansion as healthcare investment increases, device availability improves, and clinicians become more familiar with advanced Aortic Stents Grafts.

List of Top Aortic Stents Grafts Market Companies

• Cook Medical
• Terumo Corporation
• W.L. Gore & Associates
• Cardinal Health
• ENDOLOGIX
• C. R. Bard
• Medtronic
• MicroPort Scientific
• Bolton Medical
• Lombard Medical
• JOTEC

Top 2 Companies Market Share

• Medtronic: Medtronic maintains a leading competitive position in the Aortic Stents Grafts Market through its broad endovascular portfolio, global vascular-care presence, and established physician network. Its Endurant platform is used across abdominal aortic repair procedures and is designed to support challenging anatomy through flexible deployment and fixation technologies. Medtronic is estimated to hold approximately 18% of the global market in 2026, supported by strong hospital penetration and a broad range of vascular technologies. The company continues to emphasize lower-profile delivery systems, procedural precision, and long-term graft performance.
• Cook Medical: Cook Medical is another major participant, with a strong position in abdominal and complex aortic endovascular treatment. Its portfolio includes standard, fenestrated, and branched technologies that support increasingly complex anatomy. The company is estimated to account for approximately 15% of global market demand in 2026. Its Zenith family of endovascular technologies provides coverage across multiple aortic applications, while physician training and specialized planning support broader adoption of advanced procedures. Continued emphasis on customized graft configurations and complex aortic repair should help maintain the company's competitive position through the forecast period.

Investment Analysis and Opportunities

Investment in the Aortic Stents Grafts Market is increasingly directed toward technologies that improve deployment accuracy, anatomical compatibility, and long-term durability. Manufacturers are allocating resources toward lower-profile delivery systems, advanced graft materials, improved fixation mechanisms, and fenestrated or branched configurations. Approximately 46% of major product-development programs are estimated to focus on improving delivery, navigation, or deployment performance. Investment is also increasing in advanced imaging and planning software because accurate anatomical assessment is essential for selecting and positioning complex graft systems.

Healthcare providers are simultaneously investing in vascular laboratories, advanced imaging equipment, catheterization facilities, and physician training. Approximately 43% of new endovascular program investments in emerging healthcare markets are estimated to include equipment or training specifically related to minimally invasive vascular intervention. Hospitals remain the principal investment destination because they can support complex procedures and manage potential complications. Ambulatory Surgical Centers represent a smaller but developing opportunity as lower-profile devices and standardized procedural pathways make selected interventions more suitable for shorter-stay treatment.

New Product Development

New product development is centered on lower-profile delivery systems, enhanced graft flexibility, improved fixation, and better sealing around irregular anatomy. Device manufacturers are working to reduce delivery-system diameter while maintaining structural strength and deployment control. Newer platforms can provide approximately 15% lower delivery profiles than selected previous-generation systems, potentially improving access for patients with smaller or tortuous vessels. Development is also focused on reducing deployment complexity so physicians can position grafts more accurately during increasingly demanding procedures.

Complex aortic repair is another major development area, with fenestrated and branched grafts designed to preserve blood flow to important branch vessels. Approximately 18% of complex aortic repair programs at advanced vascular centers are estimated to use specialized configurations. Manufacturers are also improving three-dimensional planning workflows, patient-specific sizing, graft flexibility, and sealing technologies. Future products are expected to increasingly combine precise deployment mechanisms with improved anatomical adaptability, supporting treatment of patients who previously had limited endovascular options.

Five Recent Developments

• January 2025 – Low-Profile Device Development: Leading manufacturers accelerated development of smaller delivery systems designed to improve access through challenging vascular anatomy, with next-generation platforms targeting approximately 15% reductions in delivery-system diameter compared with selected earlier systems.
• April 2025 – Complex Aortic Repair Expansion: Advanced vascular centers increased adoption of fenestrated and branched endovascular technologies, with specialized configurations representing approximately 18% of complex aortic repair programs at selected high-volume centers.
• September 2025 – Advanced Imaging Integration: Vascular centers increased use of three-dimensional imaging and procedural planning technologies, with approximately 61% of major North American centers estimated to use advanced imaging for selected complex aortic procedures.
• February 2026 – Endovascular Platform Innovation: Manufacturers continued refining graft fixation, sealing, and deployment systems to improve treatment of challenging anatomy, with new platforms targeting approximately 20% improvements in deployment flexibility and procedural control.
• July 2026 – Outpatient Procedure Expansion: Selected healthcare providers expanded evaluation of shorter-stay endovascular pathways as lower-profile devices and standardized protocols improved procedural efficiency, with approximately 12% of eligible cases estimated to have potential for outpatient or short-stay management.

Report Coverage

The Aortic Stents Grafts Market coverage evaluates Abdominal Aortic Stent Graft and Thoracic Aortic Stent Graft products across Hospitals and Ambulatory Surgical Centers. The assessment covers market conditions from 2026 through 2035, including product adoption, minimally invasive treatment trends, device innovation, anatomical suitability, imaging requirements, procedural infrastructure, reimbursement considerations, and competitive positioning. Market segmentation is structured around the two supplied product categories and two application environments to identify the areas with the strongest commercial potential.

The regional assessment covers North America, Europe, Asia-Pacific, Middle East and Africa, and Rest of World, with emphasis on vascular-care infrastructure, procedure volumes, specialist availability, technology adoption, healthcare investment, and minimally invasive treatment penetration. Competitive analysis includes Cook Medical, Terumo Corporation, W.L. Gore & Associates, Cardinal Health, ENDOLOGIX, C. R. Bard, Medtronic, MicroPort Scientific, Bolton Medical, Lombard Medical, and JOTEC. The assessment also considers lower-profile delivery systems, fenestrated and branched grafts, advanced imaging, customized treatment planning, and evolving endovascular procedure pathways through 2035.

Aortic Stents Grafts Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 2665.22 Million in 2026
Market Size Value By	USD 3703.89 Million by 2035
Growth Rate	CAGR of 3.72% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Abdominal Aortic Stent Graft Thoracic Aortic Stent Graft By Application : Hospitals Ambulatory Surgical Centers
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample